发明名称 |
Intranasal compositions |
摘要 |
The present invention provides a liquid aqueous formulation for the intranasal administration of apomorphine, which comprises:
(a) at least about 15 mg/ml of apomorphine; and
(b) a solubilising agent selected from
(i) at least one polyoxyethylene-polyoxypropylene copolymer (poloxamer);
(ii) at least one cyclodextrin; and
(iii)
at least one cyclodextrin together with chitosan. The formulations of the invention can be used in the treatment/management of Parkinson's disease.
|
申请公布号 |
EP2057982(A1) |
申请公布日期 |
2009.05.13 |
申请号 |
EP20070254426 |
申请日期 |
2007.11.09 |
申请人 |
ARCHIMEDES DEVELOPMENT LIMITED |
发明人 |
CHENG, YU-HUI;WATTS, PETER JAMES |
分类号 |
A61K9/00;A61K31/473;A61K47/26;A61K47/34;A61K47/40 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|